Glutamate oxidase mutagenesis for diagnostic testing
AssigneeAbbott Point of Care Inc.
InventorsDan Wang, G. Bruce Collier
Life of this patent
Estimating the term…
Loading patent…
AssigneeAbbott Point of Care Inc.
InventorsDan Wang, G. Bruce Collier
Estimating the term…
The described invention provides a method for detecting a target analyte that exhibits protease enzyme activity. The described method includes contacting a sample with a hybrid oxidase enzyme engineered to exhibit increased catalytic activity over that of a starting oxidase enzyme upon cleavage of a mutated protease cleavage recognition sequence. The mutated protease cleavage recognition sequence is a recognition sequence specific for the target analyte. The described method further includes contacting a substrate with the engineered hybrid oxidase enzyme. The substrate comprises a cognate composition of matter to the engineered hybrid oxidase enzyme, and the engineered hybrid oxidase enzyme is configured to catalyze conversion of the cognate composition of matter into a detectable product upon proteolytic cleavage of the mutated protease cleavage recognition sequence by the target analyte.
A method for detecting a target analyte that exhibits protease enzyme activity, the method comprising:
Dependencies are inferred from the claim text.